Jorgina Serra-López

4PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCellular immunologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2026
Soluble Immune Checkpoints as Prognostic Biomarkers in Small Cell Lung Cancer Patients Treated with Chemotherapy and Anti-PD-L1.

|Mar 01, 2026
Baseline PD-L1 expression on circulating immune cells as a predictor of survival and immune-related adverse events in extensive-stage small-cell lung cancer patients treated with durvalumab and carboplatin-etoposide (NCT04712903 Trial).

Aida Piedra, Albert Guinart-Cuadra, Sergio Martínez-Recio

|May 11, 2024
Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors.

Leticia Alserawan, Maria Mulet, Geòrgia Anguera

|Oct 27, 2022
Association between Changes in the Patterns of Antinuclear Autoantibodies during Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events.

Leticia Alserawan, Geòrgia Anguera, Carlos Zamora Atenza

Pageof 1

Frequent Collaborators

4 joint publications

Margarita Majem Tarruella

3 joint publications

Silvia Vidal

3 joint publications

Maria Mulet

3 joint publications

Rubén Osuna-Gómez